Round 1 Winners!
Proof of Usefulness Report

Z-Score Health

Analysis completed on 3/18/2026

-40.5
Proof of Usefulness Score
Lab Mode

The submission exhibits severe red flags and contradictions. While the project description presents a sophisticated AI-powered biotech infrastructure, the actual data fields undermine its credibility entirely. The claim that 'most people have used my product' is impossible for a niche B2B enterprise biotech platform launched in 2024. Listing the target audience as 'everyone' shows a lack of market understanding, and conflating monthly revenue with 'all time marketcap: 2500000' indicates this may be a token project rather than a genuine biomedical company. The poor response quality and unverifiable, exaggerated traction claims result in a penalty score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+10
Audience Reach Impact+0
Technical Innovation+5
Evidence Of Traction-60
Market Timing Relevance+10
Functional Completeness-10
Subtotal-45
Usefulness Multiplierx0.9
Final Score-40

Project Details

Project URL
Description
Biotechnology is undergoing a fundamental shift. AI and automation are no longer enhancements—they are necessities. However, the industry remains constrained by outdated, human-dependent workflows that slow down drug discovery, clinical trials, and biomedical research. Z-Score Health is building the AI-powered infrastructure that will eliminate these bottlenecks and enable biotech companies, pharmaceutical firms, and clinical research organizations to move at the speed of innovation. We are not just another biotech company. We are not just an AI company. We are creating the foundation for AI-driven biotechnology at scale. What We Do Z-Score Health provides a full-stack AI-powered platform that integrates high-performance computing (HPC), workflow automation, and predictive analytics to accelerate biotech research and clinical trials. Our solutions are designed to automate complex biomedical data processing, ensure regulatory compliance, and scale AI-driven research across enterprises. Our platform consists of three core solutions: Anansi® – An AI-driven automation engine that optimizes machine learning deployment, data integration, and AI-driven insights for biotech research. Ascendia® – A high-performance AI computing platform that orchestrates large-scale biomedical data processing, predictive modeling, and clinical trial optimization. Asclepius® – An AI-powered pharmacogenomics platform that transforms genomic data into hyper-personalized treatment regimens, ensuring precision medicine at scale. Why Z-Score Health? AI-powered biotech is inevitable. However, most biotech companies lack the technical infrastructure to seamlessly integrate AI into their workflows. Legacy systems, fragmented data pipelines, and regulatory complexities slow down adoption. Z-Score Health eliminates these challenges by providing an enterprise-ready AI infrastructure that is built for biotech from the ground up.

Algorithm Insights

Market Position
Early stage requiring focused development
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline